SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-03-000883
Filing Date
2003-07-10
Accepted
2003-07-09 20:51:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 AVANT IMMUNOTHERAPEUTICS, INC. / SC 13G srz9464392v1.txt SC 13G 9680
  Complete submission text file 0000902664-03-000883.txt   11771
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-37761 | Film No.: 03780956
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVE NEW YORK NY 10103
Business Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVE NEW YORK NY 10103 2128414000
MILLENNIUM PARTNERS L P (Filed by) CIK: 0000851909 (see all company filings)

IRS No.: 133521699 | Fiscal Year End: 1231